share_log

Ian Sacks Sells 25,000 Shares of HealthEquity, Inc. (NASDAQ:HQY) Stock

Ian Sacks Sells 25,000 Shares of HealthEquity, Inc. (NASDAQ:HQY) Stock

伊恩·薩克斯出售25,000股醫療股權公司(納斯達克代碼:HQY)股票
kopsource ·  2022/09/22 17:32

HealthEquity, Inc. (NASDAQ:HQY – Get Rating) Director Ian Sacks sold 25,000 shares of the company's stock in a transaction dated Tuesday, September 20th. The shares were sold at an average price of $72.28, for a total transaction of $1,807,000.00. Following the completion of the transaction, the director now directly owns 126,570 shares of the company's stock, valued at $9,148,479.60. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

納斯達克股票代碼:HQY-GET評級)董事伊恩·薩克斯在一筆日期為9月20日(星期二)的交易中出售了25,000股該公司股票。這些股票的平均價格為72.28美元,總成交金額為1,807,000.00美元。交易完成後,董事現在直接持有該公司126,570股股票,價值9,148,479.60美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的,該文件可通過此超鏈接.

HealthEquity Price Performance

HealthEquity價格表現

Shares of HealthEquity stock traded up $1.65 on Thursday, hitting $73.50. The company had a trading volume of 1,162,452 shares, compared to its average volume of 749,338. The business has a 50-day simple moving average of $62.70 and a 200-day simple moving average of $62.64. The company has a market cap of $6.21 billion, a PE ratio of -99.27, a PEG ratio of 4.25 and a beta of 0.90. HealthEquity, Inc. has a 52 week low of $36.81 and a 52 week high of $74.04.

HealthEquity股價週四上漲1.65美元,至73.50美元。該公司的成交量為1,162,452股,而其平均成交量為749,338股。該業務的50日簡單移動均線切入位在62.70美元,200日簡單移動均線切入位在62.64美元。該公司市值為62.1億美元,市盈率為-99.27,聚乙二醇率為4.25,貝塔係數為0.90。HealthEquity,Inc.的52周低點為36.81美元,52周高位為74.04美元。

Get
到達
HealthEquity
健康權益
alerts:
警報:

HealthEquity (NASDAQ:HQY – Get Rating) last issued its earnings results on Tuesday, September 6th. The company reported $0.33 earnings per share for the quarter, hitting analysts' consensus estimates of $0.33. HealthEquity had a negative net margin of 7.82% and a positive return on equity of 2.86%. During the same quarter in the previous year, the business earned $0.21 earnings per share. On average, equities research analysts predict that HealthEquity, Inc. will post 0.69 earnings per share for the current fiscal year.

健康股權(納斯達克代碼:HQY-GET Rating)最近一次發佈財報是在9月6日(星期二)。該公司公佈本季度每股收益為0.33美元,超過了分析師普遍預期的0.33美元。HealthEquity的淨利潤率為負7.82%,股本回報率為正2.86%。去年同一季度,該業務每股收益為0.21美元。股票研究分析師平均預測,HealthEquity,Inc.本財年每股收益將為0.69美元。

Analyst Upgrades and Downgrades

分析師升級和下調評級

HQY has been the subject of a number of analyst reports. KeyCorp initiated coverage on shares of HealthEquity in a research report on Thursday, September 15th. They issued an "overweight" rating and a $85.00 price objective for the company. Robert W. Baird upped their target price on shares of HealthEquity from $47.00 to $67.00 and gave the company a "neutral" rating in a research note on Wednesday, September 7th. SVB Leerink upped their target price on shares of HealthEquity from $67.00 to $76.00 and gave the company an "outperform" rating in a research note on Tuesday, June 7th. Wells Fargo & Company increased their price objective on shares of HealthEquity from $95.00 to $100.00 and gave the stock an "overweight" rating in a research note on Tuesday, September 13th. Finally, The Goldman Sachs Group assumed coverage on shares of HealthEquity in a research note on Tuesday, July 12th. They set a "sell" rating and a $59.00 price objective on the stock. Two analysts have rated the stock with a sell rating, one has issued a hold rating and eleven have assigned a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $75.36.
HQY一直是多份分析師報告的主題。KeyCorp在9月15日星期四的一份研究報告中啟動了對HealthEquity股票的報道。他們對該公司的評級為“增持”,目標價為85.00美元。9月7日,週三,羅伯特·W·貝爾德在一份研究報告中將HealthEquity的目標價從47.00美元上調至67.00美元,並給予該公司“中性”評級。6月7日,週二,SVB Leerink在一份研究報告中將HealthEquity的目標價從67.00美元上調至76.00美元,並給予該公司“跑贏大盤”的評級。富國銀行將HealthEquity股票的目標價從95美元上調至100.00美元,並在9月13日(星期二)的一份研究報告中給予該股“增持”評級。最後,高盛在7月12日星期二的一份研究報告中對HealthEquity的股票進行了報道。他們為該股設定了“賣出”評級和59.00美元的目標價。兩名分析師對該股的評級為賣出,一名分析師發佈了持有評級,11名分析師對該股給予了買入評級。根據MarketBeat.com的數據,該股的共識評級為“適度買入”,共識目標價為75.36美元。

Institutional Investors Weigh In On HealthEquity

機構投資者參與HealthEquity

Several hedge funds have recently made changes to their positions in the company. Private Trust Co. NA purchased a new stake in HealthEquity in the 2nd quarter worth approximately $28,000. Assetmark Inc. lifted its position in HealthEquity by 387.1% in the 2nd quarter. Assetmark Inc. now owns 755 shares of the company's stock worth $46,000 after buying an additional 600 shares in the last quarter. Signaturefd LLC lifted its position in HealthEquity by 44.3% in the 1st quarter. Signaturefd LLC now owns 954 shares of the company's stock worth $64,000 after buying an additional 293 shares in the last quarter. Clearstead Advisors LLC bought a new position in shares of HealthEquity during the 1st quarter valued at $65,000. Finally, Eagle Bay Advisors LLC raised its holdings in shares of HealthEquity by 137.8% during the 2nd quarter. Eagle Bay Advisors LLC now owns 1,108 shares of the company's stock valued at $68,000 after purchasing an additional 642 shares in the last quarter. Hedge funds and other institutional investors own 99.43% of the company's stock.

幾家對衝基金最近對他們在該公司的頭寸進行了調整。私人信託公司NA在第二季度購買了HealthEquity的新股份,價值約28,000美元。AssetMark Inc.在第二季度將其在HealthEquity的持倉提高了387.1%。AssetMark Inc.目前持有該公司755股股票,價值46,000美元,此前該公司在上個季度又購買了600股。Signaturefd LLC在第一季度將其在HealthEquity的頭寸提高了44.3%。Signaturefd LLC現在持有該公司954股股票,價值6.4萬美元,上個季度又購買了293股。Clearstead Advisors LLC在第一季度購買了HealthEquity的新頭寸,價值6.5萬美元。最後,鷹灣顧問有限責任公司在第二季度增持了137.8%的HealthEquity股票。Eagle Bay Advisors LLC現在持有該公司1,108股股票,價值6.8萬美元,此前該公司在上個季度又購買了642股。對衝基金和其他機構投資者持有該公司99.43%的股票。

HealthEquity Company Profile

HealthEquity公司簡介

(Get Rating)

(獲取評級)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

HealthEquity,Inc.為美國的消費者和僱主提供技術支持的服務平臺。該公司提供基於雲的平臺,供個人做出健康儲蓄和支出決定、支付醫療賬單、比較治療方案和價格、接收個性化福利和臨牀信息、賺取健康激勵、增加儲蓄並做出投資選擇;以及健康儲蓄賬户。

Recommended Stories

推薦故事

  • Get a free copy of the StockNews.com research report on HealthEquity (HQY)
  • The Institutions Hold On To Darden Restaurants International
  • What Steelcase's Earnings Say About the Return to the Office?
  • These 3 Big Dividend Payers Also Boast Strong Price Growth
  • Is The Golden Age Of Homebuilding Already Over?
  • Natural Gas Prices Continue To Rally, These Stocks Should Benefit
  • 免費獲取StockNews.com關於HealthEquity(HQY)的研究報告
  • 這些機構持有達頓餐飲國際公司的股份
  • 斯蒂爾凱斯的收益説明瞭他重返辦公室的原因嗎?
  • 這三大股利支付者也擁有強勁的價格增長
  • 住房建設的黃金時代已經結束了嗎?
  • 天然氣價格繼續回升,這些股票應該會受益

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.

接受HealthEquity Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對HealthEquity和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論